Akari Therapeutics, Plc (AKTX)
NASDAQ·Healthcare·Biotechnology
$12.50
-3.85%
Mkt Cap $4.49K
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$30.00
Range $30.00 – $30.00
Implied Upside
+140.0%
Consensus $30.00 vs current $12.50
NASDAQ·Healthcare·Biotechnology
$12.50
-3.85%
Mkt Cap $4.49K
No recent rating data.
Price Target (1 analysts)
$30.00
Range $30.00 – $30.00
+140.0%
Consensus $30.00 vs current $12.50